Lung Cancer News

Latest Lung Cancer News From Medical News Today.

Total news: 24
Last news: August 29, 2007 10:00:00

Diverse Communities throughout the United States continue to be disproportionately affected by specific lung diseases such as asthma, tuberculosis, lung cancer and chronic obstructive pulmonary disease (COPD), and/or have more risk factors such as genetic predisposition, poor living conditions, and unequal access to healthcare and medications, according to the [click link for full article] - [Read more]

Avastin (bevacizumab), Roches innovative anti-cancer drug, was approved today in Europe for the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC), in combination with platinum-based chemotherapy. NSCLC is the most common form of lung cancer, a difficult to treat disease that kills over 3,000 people per day worldwide. [click link for full article] - [Read more]

Alfacell Corporation (Nasdaq: ACEL) announced that a paper published in Advances in Experimental Medicine and Biology (2007; 599: 53-60) reports that ONCONASE significantly enhances the effect of the radiation response in human non small cell lung cancer (NSCLC) in vitro and in vivo. [click link for full article] - [Read more]

Treatment with chemotherapy and bevacizumab, an anticancer drug, is associated with a greater risk of blood clots in patients arteries compared with treatment with chemotherapy only, according to a study published online in the Journal of the National Cancer Institute. [click link for full article] - [Read more]

In a grassroots effort that has grown by 5,000% in four years, more than 10,000 individuals over 30 days across 12 states will be striding toward a cure for lung cancer this Fall. Benefiting LUNGevity Foundation, these 20,000 feet are walking and running to raise money for innovative research in the diagnosis, treatment, and cure of the nations number one cancer killer. [click link for full article] - [Read more]

Cancer causing mutations occur in our bodies every day -- but luckily, we have specific genes that recognize these malignant events and keep cells from growing out of control. Only a few of these genes -- called tumor suppressors -- are currently known.Now scientists at the University of North Carolina at Chapel Hill School of Medicine and Harvard Medical School have added to the list another powerful tumor suppressor, a gene called LKB1. [click link for full article] - [Read more]

Late in session last night, the U.S. Senate unanimously reconfirmed its commitment to making lung cancer research a national public health priority. Laurie Fenton-Ambrose, president of the Lung Cancer Alliance, thanked Senator Hillary Clinton (D-NY) and Senator Chuck Hagel (R-NE) for their leadership on the resolution which reinforces the one they shepherded through the Senate last year. [click link for full article] - [Read more]

Todays passage of the Family Smoking Prevention and Tobacco Control Act by the Senate Committee on Health, Education, Labor and Pensions (HELP) is truly historic. This legislation will give the U.S. Food and Drug Administration the authority it needs to regulate the products responsible for more than 438,000 deaths each year. [click link for full article] - [Read more]

A novel radiotherapy approach has shown promise as a treatment option, and may possibly increase the cure rate, for people with early stage lung cancer who are unable to tolerate surgery, according to findings from a five-year study led by SUNY Upstate Medical University. SUNY Upstate was among 10 institutions nationwide participating in this first prospective radiotherapy study specific to high-risk patients with early stage lung cancer. [click link for full article] - [Read more]

Dr. Eli Sahar, CEO of Immunarray, makes no bones about it. "Lung cancer is one of the most lethal cancers," he says. The second most common cancer in terms of annual incidence, it has a five-year survival rate of just 15%. When you consider that there are 1.25 million new cases of lung cancer diagnosed every year worldwide, and 175,000 in the US alone, you get a picture of just how devastating this illness can be. [click link for full article] - [Read more]

Roche announced today that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive recommendation for the first-line use of Avastin in the treatment of the most common form of lung cancer, in combination with platinum based chemotherapy. The CHMPs decision is based on data from the pivotal US (E4599) study and another phase III Avastin in Lung (AVAiL) study which together demonstrate that Avastin is effective in combination with a broad chemotherapy range. [click link for full article] - [Read more]

Traditionally, PET, or positron emission tomography, has been used after radiation treatment for lung cancer to assess whether the tumor responded to treatment and whether the patients will have a chance of being cured. Using PET several weeks into treatment, researchers found a strong correlation between tumor responses during treatment and response three months after completion of the treatment. [click link for full article] - [Read more]

Combining pre-operative chemotherapy and surgery increases the average chance of survival at five years by approximately 6% compared with surgery alone.This conclusion was drawn by a team of Cochrane Researchers from the MRC Clinical Trials Unit in London after they identified 12 eligible randomised controlled trials. Data from seven of these trials were available from trial reports and were combined in a meta-analysis. The seven trials involved a total of 988 patients. [click link for full article] - [Read more]

Lung cancer patients may not need to wait till their radiation treatment is over to know if it worked. A PET scan several weeks after starting radiation treatment for lung cancer can indicate whether the tumor will respond to the treatment, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center. [click link for full article] - [Read more]

Panacea Pharmaceuticals, Inc. announced today that LC Detect(sm), the Companys serum-based lung cancer diagnostic test, is now available from Panacea Laboratories. LC Detect(sm) is a simple blood test which should facilitate the identification of lung cancer, even among individuals with early-stage disease. Panacea Laboratories, a division of Panacea Pharmaceuticals, is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA). [click link for full article] - [Read more]

ImClone Systems Incorporated (NASDAQ: IMCL) and Bristol-Myers Squibb Company (NYSE: BMY) today announced results from an open-label Phase III study of ERBITUX® (Cetuximab) plus a taxane and carboplatin in the first-line treatment for metastatic non-small cell lung cancer (NSCLC). The study did not meet its primary endpoint of progression-free survival (PFS) as assessed by an independent radiology review committee (IRRC). [click link for full article] - [Read more]

Biomoda, Inc. (OTC Bulletin Board: BMOD) today issued an in-depth discussion of its patented, early-stage cancer detection technology. In 1992 Biomoda exclusively licensed the TCPP patent from Los Alamos National Laboratories (LNAL) for lung cancer diagnosis and treatment. [click link for full article] - [Read more]

Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and hepatitis C virus (HCV) infection, today announced that it has submitted a clinical protocol with the Drug Controller General of India (DCGI) for a Phase II trial of bavituximab in combination with chemotherapy in patients with non-small cell lung cancer (NSCLC). [click link for full article] - [Read more]

Lung Cancer Survival Better in Nonsmokers Never-smokers with early stage lung cancer have significantly better survival than smokers with the disease. Researchers from the University of Alabama compared survival rates among 562 smokers and 168 never-smokers, all of whom had non-small cell lung cancer (NSCLC). The overall 5-year survival rate was greater in never-smokers (64%) compared with smokers (56%). [click link for full article] - [Read more]

Want to help people quit smoking? Get a national TV network to publicize your toll-free number. That is the message of a new study that found calls to a national smoking-cessation hotline more than tripled in the wake of news anchor Peter Jennings death from lung cancer. "Its not enough just to build a (smoking cessation) service. You also have to advertise it," said Erik Augustson, a behavioral scientist with the National Cancer Institutes Tobacco Control Research Branch. [click link for full article] - [Read more]